700 related articles for article (PubMed ID: 3011902)
1. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing.
Perl A; Looney RJ; Ryan DH; Abraham GN
J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902
[TBL] [Abstract][Full Text] [Related]
2. Influence of IgG and IgM receptor triggering on human natural killer cell cytotoxicity measured on the level of the single effector cell.
Merrill JE; Ullberg M; Jondal M
Eur J Immunol; 1981 Jul; 11(7):536-41. PubMed ID: 7286062
[TBL] [Abstract][Full Text] [Related]
3. Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells.
Bridges KR; Smith BR
J Clin Invest; 1985 Sep; 76(3):913-8. PubMed ID: 2995450
[TBL] [Abstract][Full Text] [Related]
4. Activation of cloned human natural killer cells via Fc gamma RIII.
Werfel T; Uciechowski P; Tetteroo PA; Kurrle R; Deicher H; Schmidt RE
J Immunol; 1989 Feb; 142(4):1102-6. PubMed ID: 2464637
[TBL] [Abstract][Full Text] [Related]
5. Natural killer (NK)-like cytotoxic activity of allospecific T cell receptor-gamma,delta+ T cell clones. Distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity.
Koide J; Rivas A; Engleman EG
J Immunol; 1989 Jun; 142(12):4161-8. PubMed ID: 2470816
[TBL] [Abstract][Full Text] [Related]
6. Target structure for natural killer cells: evidence against a unique role for transferrin receptor.
Dokhélar MC; Garson D; Testa U; Tursz T
Eur J Immunol; 1984 Apr; 14(4):340-4. PubMed ID: 6327320
[TBL] [Abstract][Full Text] [Related]
7. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
8. Specific effect of anti-transferrin antibodies on natural killer cells directed against tumor cells. Evidence for the transferrin receptor being one of the target structures recognized by NK cells.
Alarcón B; Fresno M
J Immunol; 1985 Feb; 134(2):1286-91. PubMed ID: 2981268
[TBL] [Abstract][Full Text] [Related]
9. NK recognition of target structures: is the transferrin receptor the NK target structure?
Newman RA; Warner JF; Dennert G
J Immunol; 1984 Oct; 133(4):1841-5. PubMed ID: 6206139
[TBL] [Abstract][Full Text] [Related]
10. p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans.
Poggi A; Pella N; Morelli L; Spada F; Revello V; Sivori S; Augugliaro R; Moretta L; Moretta A
Eur J Immunol; 1995 Feb; 25(2):369-76. PubMed ID: 7875198
[TBL] [Abstract][Full Text] [Related]
11. Fc gamma receptor signal transduction in natural killer cells. Coupling to phospholipase C via a G protein-independent, but tyrosine kinase-dependent pathway.
Ting AT; Einspahr KJ; Abraham RT; Leibson PJ
J Immunol; 1991 Nov; 147(9):3122-7. PubMed ID: 1833464
[TBL] [Abstract][Full Text] [Related]
12. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells.
Roozemond RC; Bonavida B
J Immunol; 1985 Apr; 134(4):2209-14. PubMed ID: 3855929
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage.
Vargas-Cortes M; Hammarström ML; Hammarström S; Hellström U; Perlmann P
Eur J Immunol; 1986 Jul; 16(7):795-801. PubMed ID: 3522246
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR.
van de Griend RJ; Bolhuis RL; Stoter G; Roozemond RC
J Immunol; 1987 May; 138(10):3137-44. PubMed ID: 2952709
[TBL] [Abstract][Full Text] [Related]
15. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression.
Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T
Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970
[TBL] [Abstract][Full Text] [Related]
16. Identification of a human natural killer cell target cell antigen with monoclonal antibodies.
Harris DT; Jaso-Friedmann L; Devlin RB; Koren HS; Evans DL
J Immunol; 1989 Jul; 143(2):727-35. PubMed ID: 2738407
[TBL] [Abstract][Full Text] [Related]
17. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
Bolhuis RL; Roozemond RC; van de Griend RJ
J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
19. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody.
Aramburu J; Balboa MA; Izquierdo M; López-Botet M
J Immunol; 1991 Jul; 147(2):714-21. PubMed ID: 1830071
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Gan X; Zhang L; Solomon GF; Bonavida B
Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
